Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

14.59
-0.2300-1.55%
Post-market: 14.46-0.1300-0.89%19:09 EDT
Volume:4.85M
Turnover:71.89M
Market Cap:4.73B
PE:-26.74
High:15.02
Open:14.78
Low:14.56
Close:14.82
52wk High:15.02
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:0.83
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:5.28
PE(LYR):-29.77

Loading ...

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Yesterday

JPMorgan Initiates AbCellera Biologics at Overweight With $17 Price Target

MT Newswires Live
·
Sep 29

Abcellera Biologics Inc. : JP Morgan Initiates Coverage with Overweight Rating; Target Price $17

THOMSON REUTERS
·
Sep 29

JonesTrading Sticks to Their Buy Rating for AbCellera Biologics (ABCL)

TIPRANKS
·
Sep 28

AbCellera Biologics Price Target Announced at $13.00/Share by Goldman Sachs

Dow Jones
·
Sep 24

AbCellera Biologics (ABCL) Receives a Hold from Goldman Sachs

TIPRANKS
·
Sep 24

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Sep 17

AbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause

TIPRANKS
·
Sep 17

AbCellera to Present Phase 2 Abcl635 Data for Menopause Hot Flashes at IMS World Congress 2026

Reuters
·
Sep 17

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Sep 16

AbCellera to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 03

Movement Alert|AbCellera Biologics Falls 8.02% in Regular Trading, Life Sciences Sector Broadly Under Pressure Post Dilutive Offering

Market Focus
·
Aug 29

U.S. Small Caps Finish Mixed as AbCellera Biologics Leads, Bath & Body Works Lags

Dow Jones
·
Aug 26

AbCellera rises 17.0%

TIPRANKS
·
Aug 26

Major Insider Move Signals Growing Confidence in AbCellera Biologics

TIPRANKS
·
Aug 25

Abcellera Director Michael R. Hayden Reports $570,442 Common Share Purchase

Reuters
·
Aug 25

AbCellera Biologics call volume above normal and directionally bullish

TIPRANKS
·
Aug 20

Insider Confidence Surge: Director Makes Bold Move on AbCellera Biologics

TIPRANKS
·
Aug 19

Abcellera Director John S. Montalbano Acquires Common Shares Worth $110,300

Reuters
·
Aug 19